ANRS Infectious emerging diseases (MIE), autonomous agency of Inserm, facilitates, evaluates, coordinates and funds research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases.
A central role in infectious diseases research for over 35 years
Supporting research to prevent, understand and treat infectious diseases
ANRS MIE three majors levels of action
ANRS MIE is an agency operating under the specific status of an autonomous agency within Inserm.
Patient associations, next generation of scientists, quality and ethical approach, open science
Our agency funds, coordinates, evaluates and facilitates research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging infectious diseases.
Learn more about the diseases and pathogens covered by our research
Information on the projects we fund
Our workgroups bring together researchers and representatives of civil society
Guiding and advising innovative project leaders
The agency supports a number of research platforms and networks to federate and help shape research in its field
National and international research platforms supported by the agency and designed for the scientific community
Clinical research networks and networks of young researchers
Access to data and biological collections from research promoted by the agency
The agency is a member of various networks and forges partnerships with national and international associations, organisations and initiatives
Partner sites, international global health research platforms, ad hoc partnerships
WHO, Ministry of Europe and Foreign Affairs, Global Health EDCTP3 Joint Undertaking, structuring networks
Strategic international projects and capacity-building programmes
Fighting epidemics: ANRS MIE leads WHO filovirus CORC
Collaboration with community stakeholders
Each year, the agency offers two calls for generic projects and calls for thematic projects. Some are jointly carried out with other research players
Agency's current, forthcoming and completed calls for proposals
Find out the list of calls for projects previously funded by the agency
Find out the Start programme, here to support and guide the next generation of scientific researchers
ANRS MIE is a key player in crisis preparedness and response
Facilitation and watch procedure for responding to emerging or re-emerging epidemics
A Level 1 Outbreak Response Unit for MERS-CoV, opened on 11 December 2025
This Outbreak Response Unit for several diseases is active since March 2025
Opened since January 2025 and still active since the detection of one new case in French Guiana in January 2026
A level 1 Outbreak Response Unit since December 2023, monitoring new cases in Mayotte and La Réunion
ANRS MIE continues to follow H5N1 closely since June 2024
Submit a project
Find out successful aplications.
Last updated on 31 January 2026
Share:
Trier par
Roquilly Antoine
AAP Exceptionnel
1
1 €
ROQUILLY Antoine | Anesthésie - Réanimation chirurgicale ROQUILLY Antoine Anesthésie - Réanimation chirurgicale Unité d'Investigation Clinique 9 - CIC 1413 CHU de Nantes 5 allée de l'Ile Gloriette 44093 Nantes France
de La Porte des Vaux Clémentine
DE LA PORTE DES VAUX Clémentine | Immuno-infectiologie DE LA PORTE DES VAUX Clémentine Immuno-infectiologie Hôtel-Dieu, AP-HP 1 Parvis de Notre-Dame 75004 Paris France
Bohard Louis
BOHARD Louis | Department of Infectious and Tropical Diseases, CHU de Besançon - Hospital Jean Minjoz / CNRS UMR 6249 Chrono-environnement BOHARD Louis Department of Infectious and Tropical Diseases, CHU de Besançon - Hospital Jean Minjoz / CNRS UMR 6249 Chrono-environnement 3 Boulevard Alexandre Fleming 25000 Besançon France
Melica Giovanna
MELICA Giovanna | Service de Maladies Infectieuses et Immunologie Clinique Virus,hepatologie, cancer MELICA Giovanna Service de Maladies Infectieuses et Immunologie Clinique Virus,hepatologie, cancer U955 Eq 18 GH Henri Mondor, APHP 1 rue Gustave Eiffel 94000 Creteil France
cambau emmanuelle
CAMBAU Emmanuelle | mycobacteriologie specialisee et de reference; IAME UMR1137 CAMBAU Emmanuelle mycobacteriologie specialisee et de reference; IAME UMR1137 EVREST Universite Paris Cite, APHP Bichat universite paris cite, hospital Bichat 46 rue Henri Huchard 75018 PARIS France
NOEL Nicolas
NOEL Nicolas | Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases » (IMVA-HB/IDMIT/UMRS1184), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France IDMIT NOEL Nicolas Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases » (IMVA-HB/IDMIT/UMRS1184), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France IDMIT COVIR Université Paris Saclay, INSERM, CEA 78 rue du général Leclerc 94270 Le Kremlin Bicêtre France
LAUNAY Odile
LAUNAY Odile | CIC Vaccinologie Cochin Pasteur LAUNAY Odile CIC Vaccinologie Cochin Pasteur Hôpital Cochin 27 rue du Faubourg Saint Jacques 75679 PARIS CEDEX 14 FRANCE
KERNEIS Solen
KERNEIS Solen | IAME UMR 1137 KERNEIS Solen IAME UMR 1137 INSERM DR PARIS IDF CENTRE NORD (P7) 16, rue Henri Huchard 75013 Paris France
Boyer Pierre
BOYER Pierre | Pathogens Host Arthropod Vectors Interfaces (PHAVI) BOYER Pierre Pathogens Host Arthropod Vectors Interfaces (PHAVI) Team 3: Tick-Borne Bacterial Infection and human susceptibility 1-3 rue koeberlé 67000 Strasbourg France
